Drug Database
Back to search

Belgium· BE-AMP-SAM417636-00

ArkoFlex 435 mg

A other antiinflammatory and antirheumatic agents, non-steroids product containing harpagophytum, powder, registered in Belgium by Laboratoires Arkopharma. The same ATC class is registered in 5 of our 19 countries.

ATC M01AX

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedArkoFlex 435 mgATCM01AXREGISTER NO.BE-AMP-SAM417636-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about harpagophytum, powderAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Harpagophytum, powder is registered in 5 of 19 countries.

Countries holding a registration under ATC M01AX (other antiinflammatory and antirheumatic agents, non-steroids), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search harpagophytum, powder products by name

Harpagophytum, powder · ATC M01AX

5 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Harpagophytum, Powder
Manufacturer
Laboratoires Arkopharma
Country
Belgium (BE)
ATC code
M01AX
ATC class
Other antiinflammatory and antirheumatic agents, non-steroids
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3341070

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under M01AX

Other antiinflammatory and antirheumatic agents, non-steroids, as other registers publish it.

All harpagophytum, powder products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/79e813ed-800c-4446-b52a-8ad37542d064
GET /v1/drugs/79e813ed-800c-4446-b52a-8ad37542d064?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "ArkoFlex 435 mg",
  "name_fr": "ArkoFlex 435 mg",
  "name_nl": "ArkoFlex 435 mg",
  "amp_code": "SAM417636-00",
  "strengths": [
    "435.0000",
    "435.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Harpagophytum, Powder"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Other Antiinflammatory and Antirheumatic Agents, Non-Steroids",
  "authorisation_numbers": [
    "BE-TU417636"
  ]
}
API referenceMCP serverPlans

See everything about harpagophytum, powder.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console